Key Insights:
- Market Growth: Understand the significant growth trajectory of the Other POC Products segment, which is expected to reach US$3.3 Billion by 2030 with a CAGR of a 6.1%. The Drugs-of-Abuse Testing Products segment is also set to grow at 6.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $7.5 Billion in 2023, and China, forecasted to grow at an impressive 11.2% CAGR to reach $10.0 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Point-of-Care/Rapid Diagnostics Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Point-of-Care/Rapid Diagnostics Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Point-of-Care/Rapid Diagnostics Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Abbott Laboratories, AccuBioTech Co., Ltd., Becton, Dickinson and Company, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 13 Featured):
- Abbott Laboratories
- AccuBioTech Co., Ltd.
- Becton, Dickinson and Company
- Chembio Diagnostic Systems, Inc.
- Danaher Corporation
- EKF Diagnostics Holdings PLC
- Instrumentation Laboratory
- Johnson & Johnson
- Nova Biomedical Corporation
- PTS Diagnostics
- Quidel Corporation
- Roche Diagnostics (Schweiz) AG
- Sekisui Diagnostics LLC
- Siemens AG
- Trinity Biotech PLC
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AccuBioTech Co., Ltd.
- Becton, Dickinson and Company
- Chembio Diagnostic Systems, Inc.
- Danaher Corporation
- EKF Diagnostics Holdings PLC
- Instrumentation Laboratory
- Johnson & Johnson
- Nova Biomedical Corporation
- PTS Diagnostics
- Quidel Corporation
- Roche Diagnostics (Schweiz) AG
- Sekisui Diagnostics LLC
- Siemens AG
- Trinity Biotech PLC
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 376 |
Published | October 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 27.7 Billion |
Forecasted Market Value ( USD | $ 46.4 Billion |
Compound Annual Growth Rate | 7.7% |
Regions Covered | Global |